Cargando…
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
Cancer pharmacogenomics is an evolving landscape and has the potential to significantly impact cancer care and precision medicine. Harnessing and understanding the genetic code of both the patient (germline) and the tumor (somatic) provides the opportunity for personalized dose and therapy selection...
Autor principal: | Patel, Jai N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948716/ https://www.ncbi.nlm.nih.gov/pubmed/27471406 http://dx.doi.org/10.2147/PGPM.S62918 |
Ejemplares similares
-
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development
por: Tarantino, Paolo, et al.
Publicado: (2019) -
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
por: Hippman, Catriona, et al.
Publicado: (2019) -
Scientific Challenges and Implementation Barriers to Translation of Pharmacogenomics in Clinical Practice
por: Lam, Y. W. Francis
Publicado: (2013) -
Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges
por: Arwood, MJ, et al.
Publicado: (2016) -
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives
por: Arbitrio, Mariamena, et al.
Publicado: (2018)